UK Cardiac Biomarker Market: Global Market Size, Industry Growth, Future Prospects, Opportunities and Forecast 2019-2025


Posted January 28, 2020 by mansi3210

UK Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type, By Application, By Location of Testing and Forecast 2019-2025

 
UK cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.7% during the forecast period. The major factor that contribute in the market growth include increasing CVDs in the country coupled with availability of advanced diagnostic technology for heart related diseases in the country. Furthermore, the nation has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease. According to one of the reports published by British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. Moreover, growing preference towards personalized medicine further provide substantial opportunity to the market.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/uk-cardiac-biomarker-market

The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the UK cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.

A full report of UK Cardiac Biomarker Marketis available at https://www.omrglobal.com/industry-reports/uk-cardiac-biomarker-market

UK Cardiac Biomarker Market- Segmentation

by Type

• Creatine kinase (CK-MB)
• Troponins (T, I)
• Myoglobin
• Natriuretic peptides (BNP & NT-PROBNP)
• Ischemia modified albumin
• Others

by Application

• Myocardial infraction
• Congestive heart failure
• Acute coronary syndrome
• Atherosclerosis
• Others

by Location of Testing

• Laboratory testing
• Point of care testing

Visit here to know more about https://www.omrglobal.com/request-sample/uk-cardiac-biomarker-market

Company Profiles

• Abbott Laboratories
• BioMérieux S.A.
• Cisbio Bioassays SAS
• Danaher Corp.
• F. Hoffmann-La Roche AG
• HyTest Ltd
• Merck KGaA
• Randox Laboratories Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mansi
Phone 06467557667
Business Address Indore, india
Country India
Categories Biotech , Health , Technology
Tags health , market research , pharmaceutical , uk cardiac biomarker market
Last Updated January 28, 2020